Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

6.370 +0.170 (+2.74%)
Streaming Delayed Price Updated: 12:56 PM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 334,551
Open 6.000
Bid (Size) 6.360 (1)
Ask (Size) 6.470 (1)
Prev. Close 6.200
Today's Range 5.750 - 6.460
52wk Range 0.4409 - 6.780
Shares Outstanding 55,096,537
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why DBV Technologies (DBVT) Stock Is Skyrocketing
DBV Technologies secured up to $306.9M to advance its Viaskin Peanut program. The funding supports FDA submission, commercialization and ongoing pediatric peanut allergy treatment research. 
Via Benzinga
Exposures Product Safety

Performance

YTD
+96.0%
+96.0%
1 Month
+43.1%
+43.1%
3 Month
+102.3%
+102.3%
6 Month
+810.0%
+810.0%
1 Year
+308.3%
+308.3%

More News

Read More
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected
Via Benzinga
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets'
Via Benzinga
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
From DBV Technologies S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
From DBV Technologies S.A.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
From DBV Technologies S.A.
Via GlobeNewswire
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids
Via Benzinga
Exposures Product Safety
Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows
Via Benzinga
Topics Stocks
Exposures US Equities
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Via Benzinga
DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old
From DBV Technologies S.A.
Via GlobeNewswire
Information regarding the total number of voting rights and  total number of shares of the Company as of November 30, 2024
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Announces Plan to Implement ADS Ratio Change
From DBV Technologies S.A.
Via GlobeNewswire
DBV Technologies Reports Third Quarter 2024 Financial Results
From DBV Technologies S.A.
Via GlobeNewswire
Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is DBV Technologies S.A. - American Depositary Shares publicly traded?
Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.
What exchange does DBV Technologies S.A. - American Depositary Shares trade on?
DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?
The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market
What is the current price of DBV Technologies S.A. - American Depositary Shares?
The current price of DBV Technologies S.A. - American Depositary Shares is 6.370
When was DBV Technologies S.A. - American Depositary Shares last traded?
The last trade of DBV Technologies S.A. - American Depositary Shares was at 03/31/25 12:56 PM ET
What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?
The market capitalization of DBV Technologies S.A. - American Depositary Shares is 350.96M
How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?
DBV Technologies S.A. - American Depositary Shares has 351M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.